Riskpilot← Back to searchSign inGet full accessMØLHOLM-KLINIKKEN EJENDOM ApS
APSActiveCVR 17473093Koldingvej 2Rental and operating of own or leased real estate · NACE 6820Est. 1993— employees
Revenue 2024
DKK 7,4M
+2% vs 2023
EBITDA margin
100.0%
+2% vs 2023
Equity ratio
34.1%
Financial strength
Net profit 2024
DKK -4,2M
-248% vs 2023
| Revenue | DKK 7,4M | +2% |
| EBITDA | DKK 7,4M | +2% |
| Net profit | DKK -4,2M | -248% |
| Total assets | DKK 68,5M | -6% |
| Equity | DKK 23,3M | -15% |
| Employees | — | — |
Legal name
MØLHOLM-KLINIKKEN EJENDOM ApS
CVR number
17473093
Legal form
Anpartsselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
1. december 1993
Share capital
DKK 1.000.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af 2 bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er udlejning af fast ejendom.
Address
Koldingvej 2
Email
kirkbi@kirkbi.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.042 | 6.750 | 5.626 | 5.544 | 5.655 | 5.772 | 5.889 | 6.008 | 8.089 | 3.822 | 6.661 | 7.251 | 7.374 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 8.042 | 6.750 | 5.626 | 5.544 | 5.655 | 5.772 | 5.889 | 6.008 | 8.089 | 3.822 | 6.661 | 7.251 | 7.374 |
| Depreciation & amort. | -2.458 | -23.220 | -1.726 | -1.724 | -1.724 | -1.673 | -1.673 | -1.672 | -5.418 | -1.864 | -1.864 | -1.864 | -8.864 |
| EBIT | 5.585 | -16.470 | 3.900 | 3.820 | 3.931 | 4.099 | 4.216 | 4.336 | 2.671 | 1.958 | 4.797 | 5.387 | -1.490 |
| Net financials | -3.340 | -2.795 | -2.135 | -1.312 | -1.387 | -2.153 | -513 | -496 | -661 | -390 | -413 | -1.408 | -1.573 |
| Profit before tax | 2.244 | -19.265 | 1.765 | 2.496 | 2.700 | 1.946 | 3.703 | 3.839 | 2.010 | 1.568 | 4.384 | 3.979 | -3.063 |
| Tax | 907 | 745 | 501 | 823 | 748 | 610 | 1.018 | 1.057 | 1.485 | 611 | 1.234 | 1.148 | 1.141 |
| Net profit | 1.337 | -20.010 | 1.264 | 1.673 | 1.952 | 1.336 | 2.685 | 2.782 | 525 | 957 | 3.150 | 2.831 | -4.204 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 97.687 | 74.914 | 75.553 | 77.059 | 72.866 | 70.404 | 69.116 | 67.614 | 76.935 | 73.456 | 75.668 | 72.968 | 68.538 |
| Equity | 9.018 | 21.010 | 21.860 | 23.446 | 20.591 | 20.613 | 20.299 | 20.081 | 20.606 | 21.563 | 24.713 | 27.544 | 23.340 |
| Long-term debt | 47.302 | 46.582 | 46.703 | 46.090 | 44.997 | 43.905 | 43.127 | 40.620 | 37.374 | 35.098 | 33.406 | 31.806 | 29.878 |
| Short-term debt | 41.367 | 7.322 | 6.990 | 7.524 | 7.279 | 5.886 | 5.690 | 6.913 | 18.955 | 16.795 | 17.549 | 13.618 | 15.320 |
| Total debt | 88.669 | 53.904 | 53.693 | 53.614 | 52.275 | 49.791 | 48.817 | 47.533 | 56.329 | 51.893 | 50.955 | 45.424 | 45.198 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
34.1%
This company
38.2%
Market median
+11% vs market
20122024
Return on equity
-18.0%
This company
18.4%
Market median
-198% vs market
20122024
Net profit margin
-57.0%
This company
8.1%
Market median
-804% vs market
20122024
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20122024
Debt / equity
1.94×
This company
0.62×
Market median
-213% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-08-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2018-08-01 – 2019-07-31
- Annual report 2018Filed via CVR / Virk · Period 2017-08-01 – 2018-07-31
- Annual report 2017Filed via CVR / Virk · Period 2016-08-01 – 2017-07-31
- Annual report 2016Filed via CVR / Virk · Period 2015-08-01 – 2016-07-31
- Annual report 2015Filed via CVR / Virk · Period 2014-08-01 – 2015-07-31
- Annual report 2014Filed via CVR / Virk · Period 2013-08-01 – 2014-07-31
- Annual report 2013Filed via CVR / Virk · Period 2012-08-01 – 2013-07-31
- Annual report 2012Filed via CVR / Virk · Period 2011-08-01 – 2012-07-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SP Management | Management | 2019 | — | — |
ET | Audit | 1993 | — | — |
MB Management | Management | 2013 | — | — |
JB Management | Management | 2011 | — | — |
PI | Audit | 1993 | — | — |
OM Management | Management | 2013 | — | — |
EG Chief Executive Officer | Chief Executive Officer | 2001 | — | — |
HL Management | Management | 1993 | — | — |
SO Management | Management | 1993 | — | — |
PE Management | Management | 1993 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1993 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 1993 | — | — | |
| Chairman | 2011 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 1993 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2007 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KIRKBI Investment Management A/S | Company | 100.0% | 100.0% | 2019 |
DANSPINE ApS | Company | 25.0% | 25.0% | 2015 |
BELAIR MEDICAL ApS | Company | 20.0% | 20.0% | 2015 |
LEIF CORYDON ApS | Company | 25.0% | 25.0% | 2015 |
JULIUS F.L. ApS | Company | 10.0% | 10.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KIRKBI A/S
MØLHOLM-KLINIKKEN EJENDOM ApS Board members of MØLHOLM-KLINIKKEN EJENDOM ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steen Pedersen | Management | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Mogens Bach Pedersen | Management | 0 companies |
| Jesper Bøje | Management | 0 companies |
| PricewaterhouseCoopers I/S | Audit | 0 companies |
| Ole Madsen | Management | 0 companies |
| Erik Gregersen | Chief Executive Officer | 0 companies |
| Hans Lybecker | Management | 0 companies |
| Steen Ole Kofod | Management | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Helle Kofod | Board of Directors | 0 companies |
| Leif Corydon | Board of Directors | 0 companies |
| Kim Bubbi Boe | Board of Directors | 0 companies |
| Jens Peter Toft | Chairman | 0 companies |
| Kurt Hedegaard Carstensen | Chairman | 0 companies |
| Asger Gert Larsen | Board of Directors | 0 companies |
| Siems Jørgen Siemssen | Board of Directors | 0 companies |
| Ib Skovbo | Board of Directors | 0 companies |
| Peter Bjerring | Chairman | 0 companies |
| Sidsel Marie Kristensen | Board of Directors | 0 companies |
| Kenni Foldager | Board of Directors | 0 companies |
| Jens Fromholt Larsen | Board of Directors | 0 companies |